Comparison of drugs for asthma

Palmer, K N; Legge, J S; Gaddie, J
March 1971
British Medical Journal;3/27/1971, Vol. 1 Issue 5751, p727
Academic Journal
No abstract available.


Related Articles

  • New hope for asthma sufferers.  // Better Homes & Gardens;Apr95, Vol. 73 Issue 4, p59 

    Reports on the development of a new drug designed to stop asthma attacks called zileuton. Comparison of the effectivity of the drug with conventional asthma oral medications; Views of physician John J. Murray on the benefits of the drug; Projected marketing of the drug in the United States upon...

  • Asthma.  // Ebony;Jul2004, Vol. 59 Issue 9, p77 

    Provides information on asthma. Characteristics of asthma; Symptoms of asthma; Drugs for treating asthma; Significance of an Asthma Control Plan developed by doctors.

  • Singulair case study.  // Singulair Case Study: Building a Successful Launch Strategy Thro;Mar2004, p1 

    Presents a case study on the launch strategy of Singulair, drug in the treatment of asthma, developed by Merck & Co. Inc. Role played by the drug in the treatment of asthma; Role of promotion in the asthma market; Information on the launch strategy adopted by the company; Comparison of the key...

  • US asthma guidelines stress early steroid use. Bryan, Jenny // BMJ: British Medical Journal (International Edition);03/01/97, Vol. 314 Issue 7081, p628 

    Highlights guidelines on the management of asthma released by the United States National Institutes of Health. Need for early use of anti-inflammatory drugs; Classification of asthma severity; Comparison with British guidelines.

  • Comparison of Aerosol Ipratropium Bromide and Salbutamol in Chronic Bronchitis and Asthma. Petrie, G.R.; Palmer, K.N.V. // British Medical Journal;2/22/1975, Vol. 1 Issue 5955, p430 

    Examines the comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma in Great Britain. Assessment of the changes in airways resistance; Effectivity of salbutamol in patients with asthma; Result of the combination of two drugs.

  • CORRESPONDENCE. Gleeson, Michael; Milford, C.A.; Dover, Simon; Havard, J.D.J.; Robbins, J.A.B.; Dann, T.C.; Symon, David N.K.; Khot, A.; Burn, R.; Whyte, B.; Philip, C.J.; Davies, Brian H.; Mullins, J.; Johnson, Andrew J.; Neville-Smith, C.H.; Brandon, Sydney; Harrison, Robert F.; Brennan, Mary // British Medical Journal (Clinical Research Edition);9/1/1984, Vol. 289 Issue 6444, p555 

    Presents letters to the editor related to medicine. Cause of the functional disorder of the oropharynx; Comparison between death certification and cremation certification; Increase in sales of drugs for asthma.

  • Cromolyn Sodium in the Management of the Child with Asthma: A Symposium.  // Clinical Pediatrics;Sep1973, Vol. 12 Issue 9, p518 

    Examines the effectiveness of cromolyn sodium in the treatment of asthma in children. Role of the drug in interfering with the release of the chemical mediators of the allergic responses; Comparison of the effectiveness of the drug with placebo; Reduction in asthmatic symptoms in patients.

  • Preventing exercise-induced asthma.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p21 

    Reports that salmeterol xinafoate prevents exercise-induced asthma, according to Dr. James P. Kemp. Study results by Kemp on prophylaxis against exercise-induced asthma in patients; Comparison of drugs provided for research participants; Duration of the salmeterol's effectivity.

  • BY THE NUMBERS.  // Infectious Diseases in Children;Apr2011, Vol. 24 Issue 4, p1 

    A graph is presented that shows the effect of the drug omalizumab on asthma.

  • Focus on fluticasone propionate: An inhaled corticosteroid for use in the maintenance treatment of.. Milch, Lara R.; White, C. Michael // Formulary;Dec96, Vol. 31 Issue 12, p1165 

    Discusses the results of studies assessing the effectiveness of fluticasone propionate in reducing the symptoms of asthma. Comparison with beclomethasone dipropionate; Common adverse effects of the drug; Association with growth suppression in children. INSET: Formulary considerations..


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics